Search Symbol

Most Active Stocks

NIACL

HDFCBANK

DMART

VBL

TATAMOTORS

ICICIBANK

JAYNECOIND

RELIANCE

BHARTIARTL

EBGNG

AXISBANK

TCS

INFY

WAAREEENER

AMBER

KOTAKBANK

M&M

SBIN

INDIGO

Aurobindo Pharma Limited

Drug Manufacturers - Specialty & Generic | Healthcare

Company Overview

Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally. The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and provides project-based chemistry contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

Key Information

Market Cap

665877807104

Current Price

1101.4

52 Week Range

1010.0 - 1592.0

Previous Close

1138.5

Open

1139.0

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Contact Details

Address

Galaxy, Plot No. 1, 22nd-24th Floor Plot No.1, Survey No.83/1 Hyderabad Knowledge City,Raidurg Panmakt, Hyderabad, 500032, India

Phone

+91-40667-25000

Fax

+91-40670-74044

Website

https://www.aurobindo.com

Financials

Day Low

1100.0

Day High

1142.3

Dividend Yield

0.4

PE Ratio

18.427305

Earnings Per Share

59.77

Beta

0.204

EBITDA

66054397952

Book Value

562.371

EPS

68.60213

Company Officers

Name	Title	Age	Year Born
Mr. Kambam Nithyananda Reddy	Vice Chairman & MD	66	1958
Mr. Mettu Madan Mohan Reddy	Whole-Time Director	64	1960
Dr. Makkapati Satakarni B.E., M.B.A., Ph.D.	President of Biologics, CEO of Biologics, Vaccines and Peptid & Director	43	1981
Mr. Santhanam Subramanian	Chief Financial Officer	63	1961
Dr. S. Vijaya Kumar	President of Technical	58	1966
Mr. B. Adi Reddy	Compliance Officer & Company Secretary	-	-
Mr. G. P. Prasad	Senior Vice President of Global Finance & Operations	-	-
Dr. Sudhir Bimal Singhi	Head of Global Finance Operations	55	1969
Dr. A. Rama Mohana Rao	Chief Quality Officer -Corporate QA	62	1962
Dr. V. K. Handa	President of Chemical Research	72	1952